PCSK9 and early-onset autosomal dominant Alzheimer disease: We characterised the phenotypic consequences of genetic variation at PCSK9 in a large, general population sample focussing on therapeutically relevant biomarkers, cardiovascular disease (CVD), individual CVD components and non-CVD outcomes such as cancer, Alzheimer’s disease, and chronic obstructive pulmonary disease (COPD).